Approval · Notice of Compliance 29201 · 2022
ATARAX: Notice of Compliance 29201
Issued October 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29201
- Date
- October 14, 2022
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATARAX | 00024694 | Marketed |
Medicinal ingredients
- HYDROXYZINE HCL 10 MG per 5ML